Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2023 08:09 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results

PLEASANTON, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company” or “ProSomnus”) (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”),...
July 13, 2023 08:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation

PLEASANTON, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (OSA), announced plans to design a...
July 06, 2023 08:29 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Announces Second Quarter 2023 Investor Call and Business Update

PLEASANTON, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), will report its strong second...
June 28, 2023 08:00 ET | Source: ProSomnus Sleep Technologies, Inc.

71% of Self-identified Snorers Have Never Consulted a Healthcare Professional

PLEASANTON, Calif., June 28, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), announced the results of a...
June 08, 2023 16:08 ET | Source: ProSomnus Sleep Technologies, Inc.

Data Presented at the 2023 SLEEP Annual Meeting Strengthens Evidence for ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea

PLEASANTON, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (OSA), announced the presentation of...
May 30, 2023 08:00 ET | Source: ProSomnus Sleep Technologies, Inc.

Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea

PLEASANTON, Calif., May 30, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (OSA), announced the...
May 09, 2023 16:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Reports First Quarter 2023 Financial Results

PLEASANTON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company” or “ProSomnus”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea...
April 26, 2023 09:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences

PLEASANTON, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will...
April 24, 2023 16:05 ET | Source: ProSomnus Sleep Technologies, Inc.

Study to be Presented at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference Demonstrates Efficacy of ProSomnus Precision Oral Appliances

PLEASANTON, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today...
April 18, 2023 08:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus® Announces Publication of Four Accepted Abstracts in the Journal of Dental Sleep Medicine in Advance of Annual Meeting

PLEASANTON, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right